Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.
Hayashi M, Nakazawa K, Hasegawa Y, Horiguchi J, Miura D, Ishikawa T, Takao S, Kim SJ, Yamagami K, Miyashita M, Konishi M, Shigeoka Y, Suzuki M, Taguchi T, Kubota T, Tanino H, Yamada K, Narui K, Kimura K, Akazawa K, Kohno N; JONIE STUDY GROUP.
Hayashi M, et al. Among authors: kim sj.
Anticancer Res. 2019 Aug;39(8):4305-4314. doi: 10.21873/anticanres.13596.
Anticancer Res. 2019.
PMID: 31366522
Clinical Trial.